Development of a benzopyran-containing androgen receptor antagonist to treat antiandrogen-resistant prostate cancer

ChemMedChem

Volumn 5, Issue 4, 2010, Pages 529-533

  Oh, Sangmi ^a   Nam, Hye Jin ^a   Park, Jongmin ^a   Beak, Sung Hee ^a   Park, Seung Bum ^a  

^a Seoul National University   (South Korea)

Author keywords

Androgen; Antitumor agents; Benzopyran fused polycycles; Drug resistance; Receptors

Indexed keywords

ANTIANDROGEN; BENZOPYRAN DERIVATIVE; BICALUTAMIDE; MDV 3100; PF 0998425; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS; BENZOPYRANS; CELL LINE; HUMANS; MALE; MOLECULAR CONFORMATION; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 77950642565     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200900509     Document Type: Article

References (24)

1. A. O. Brinkmann, J. Trapman, Nat. Med. 2000, 6, 628-629.
2. Y. Chen, C. L. Sawyers, H. I. Scher, Curr. Opin. Pharmacol. 2008;8:440-448.
3. G. Andriole, N. Bruchovsky, L. W. K. Chung, A. M. Matsumoto, R. Rittmas-ter, C. Roehrborn, D. Russell, D. Tindall, J. Urol. 2004, 172, 1399-1403.
4. C. Ntais, A. Polycarpou, A. Tsatsoulis, Eur. J. Endocrinol. 2003, 149, 469-477.
5. H. Koch, Drugs Today 1984, 20, 561-574.
6. Y. Fradet, Expert Rev. Anticancer Ther. 2004, 4, 37-48.
7. H. Miyamoto, E. M. Messing, C. S. Chang, Prostate 2004, 61, 332-353.
8. M. Urushibara, J. Ishioka, N. Hyochi, K. Kihara, S. Hara, P. Singh, J. T. Isaacs, Y. Kageyama, Prostate 2007, 67, 799-807.
9. a) J. Veldscholte, C. Ris-Stalpers, G. G. J. M. Kuiper, G. Jenster, C. Berre-voets, E. Claassen, H. C. J. van Rooij, J. Trapman, A. O. Brinkmann, E. Mulder, Biochem. Biophys. Res. Commun. 1990, 173, 534-540
10. b) J. Veld-scholte, C. A. Berrevoets, A. O. Brinkmann, J. A. Grootegoed, E. Mulder, Biochemistry 1992, 31, 2393-2399
11. C) J. Veldscholte, C. A. Berrevoets, E. Mulder, J. Steroid Biochem. Mol. Biol. 1994, 49, 341-346.
12. T. Hara, J. Miyazaki, H. Araki, M. Yamaoka, N. Kanzaki, M. Kusaka, M. Miyamoto, Cancer Res. 2003, 63, 149-153.
13. C. E. Bohl, W. Gao, D. D. Miller, C. E. Bell, J. T. Dalton, Proc. Natl. Acad. Sci. USA 2005, 102, 6201-6206.
14. P. L. McGinley, J. T. Koh, J. Am. Chem. Soc. 2007, 129, 3822-3823.
15. C. Tran, S. Ouk, N. J. Clegg, Y. Chen, P. A. Watson, V. Arora, J. Wongvipat, P. M. Smith-Jones, D. Yoo, A. Kwon, T. Wasielewska, D. Welsbie, C. D. Chen, C. S. Higano, T. M. Beer, D. T. Hung, H. I. Scher, M. E. Jung, C. L. Sawyers, Science 2009, 324, 787-790.
16. J. J. Li, D. M. Iula, M. N. Nguyen, L.-Y. Hu, D. Dettling, T. R. Johnson, D. Y. Du, V. Shanmugasundaram, J. A. Van Camp, Z. Wang, W. G. Harter, W.-S. Yue, M. L. Boys, K. J. Wade, E. M. Drummond, B. M. Samas, B. A. Lefker, G. S. Hoge, M. J. Lovdahl, J. Asbill, M. Carroll, M. A. Meade, S. M. Ciotti, T. Krieger-Burke, J. Med. Chem. 2008, 51, 7010-7014.
17. S. K. Ko, H. J. Jang, E. Kim, S. B. Park, Chem. Commun. 2006, 2962-2964.
18. a) H. An, S.-J. Eum, M. Koh, S. K. Lee, S. B. Park, J. Org. Chem. 2008, 73, 1752-1761
19. b) R. Sagar, S. B. Park, J. Org. Chem. 2008, 73, 3270-3273
20. C) Y. Kim, J. Kim, S. B. Park, Org. Lett. 2009, 11, 17-20.
21. a) S.-C. Lee, S. B. Park, J. Comb. Chem. 2006, 8, 50-57
22. b) S.-C. Lee, S. B. Park, J. Comb. Chem. 2007, 9, 828-835
23. c) S.-C. Lee, S. B. Park, Chem. Commun. 2007, 3714-3716
24. D) S. O. Park, J. Kim, M. Koh, S. B. Park, J. Comb. Chem. 2009, 11, 315-326.